Teradyne, Inc. Common Stock (TER) — Analysis Summary
Teradyne, Inc. Common Stock (TER) has a market cap of $53.40B with year-over-year revenue growth of +13.1%. Net margin stands at 17.4%. The stock trades at a P/E ratio of 62.5.
Key Takeaways
- Revenue changed +13.1% year-over-year
- Net margin of 17.4%
- P/E ratio of 62.5
Compared to other companies in the INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS sector, TER posted revenue growth of +13.1% and trades at a P/E of 62.5.
Teradyne, Inc. Common Stock (TER)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems, and wireless testing for devices. The firm entered the industrial automation market in 2015 and sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies, directly and indirectly, through its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Sector
INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS
Employees
6,600
Headquarters
NORTH READING, MA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.52
Dividend Yield
0.15%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.